We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current BCYC market cap is 660.22M. The company's latest EPS is USD -3.7731 and P/E is -5.84.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 3.19M | 4.9M | 11.4M | 5.35M | 19.53M |
| Operating Income | -21.82M | -41.8M | -35.86M | -66.57M | -31.72M |
| Net Income | -29.98M | -39.06M | -42.6M | -49.9M | -26.56M |
| Year End December 30 2022 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 13.8M | 10.39M | 11.7M | 14.46M |
| Operating Income | -26.3M | -51.96M | -65.62M | -106.26M |
| Net Income | -30.61M | -51.01M | -66.82M | -112.72M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 410.61M | 428.8M | 454.17M | 638.68M | 547.14M |
| Total Liabilities | 139.83M | 185.64M | 234.07M | 222.66M | 191.1M |
| Total Equity | 270.78M | 243.16M | 220.1M | 416.02M | 356.05M |
| Year End December 30 2022 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 110.19M | 161.15M | 479.79M | 410.61M |
| Total Liabilities | 17M | 65.69M | 133.54M | 139.83M |
| Total Equity | 93.2M | 95.46M | 346.25M | 270.78M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -86.11M | -46.41M | -12.32M | -13.34M | -70.87M |
| Investing | -18.99M | -2.1M | -2.38M | -2.88M | -12k |
| Financing | 6.69M | 2.72M | 15.01M | 249.64M | 1.87M |
| Year End December 30 2022 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -28.61M | -17.79M | -14.79M | -86.11M |
| Investing | -1.56M | -1.2M | -2.03M | -18.99M |
| Financing | 58.44M | 62.84M | 320.73M | 6.69M |
| Market Cap | 660.22M |
| Price to Earnings Ratio | -5.84 |
| Price to Sales Ratio | 45.49 |
| Price to Cash Ratio | 1.94 |
| Price to Book Ratio | 2.43 |
| Dividend Yield | - |
| Shares Outstanding | 29.87M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.09 (0.41%) |
| Company Name | Bicycle Therapeutics PLC |
| Address |
b900 cambridge CB22 3AT |
| Website | https://www.bicycletherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
